Research Solutions, Inc · NASDAQ:RSSS
Research Solutions — Q3 2025 Earnings Presentation
35 slides from Research Solutions's earnings presentation, May 8, 2025
Slide 1: Investor Presentation
Investor Presentation Sosearch
Slide 2: Agenda
01 04 What We Do Outlook 02 05 Market Opportunity Financials 03 Business Model Research Solutions Agenda Overview INVESTOR PRESENTATION
Slide 3: Forward-Looking Statements
Forward-Looking Statements Research Solutions Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statement
Slide 4: What We Do
What We Do End-To-End Al Platform For Research Research Solutions INVESTOR PRESENTATION 4
Slide 5: Our Mission
Our Mission To Advance the World’s Knowledge by Simplifying Research
Slide 6: Investment Summary
Investment Summary Large & Growing Market Opportunity Driven By The Digitization Of Research & Adoption Of Al-Enabled Workflows Stable Non-Cyclical Demand From Mission-Critical R&D Customers Across Market Cycles Differentiated SaaS Platform Leveraging Proprietary Data & Advanced Al To Drive Research
Slide 7: 3.5x +1,580bps 7x+
+10% 3.5x +20% +1,580bps 7x+ 15x+ +50% 4x+ Source: Company filings and Press Releases
Slide 8: Our solutions
Our solutions Scite Article Galaxy References Future Scite Research Solutions INVESTOR PRESENTATION 8
Slide 9: Yearly Number of Publications (M)
Yearly Number of Publications (M) 1 2 3 4 5 6 7 0 1900 1905 1910 1915 1920 1925 1930 1935 1940 1945 1950 1955 1960 1965 1970 1975 1980 1985 1990 1995 2000 2005 2010 2015 2020 2025
Slide 10: Verifiable AI Built for Research
Verifiable Al Built for Research Scite.ai provides cited responses built on the largest database of scholarly content View and edit search Table of contents to strategy and reference know where you are selection process I a van prompt Export. ae used across all responses Assistant's response | ©? a
Slide 11: Our SaaS platform enables researchers to be more productive
Our SAAS platform enables researchers to be more productive while unlocking significant cost-savings for academic & corporate institutions Benefits for Researchers Benefits for Academic & Corporate Institutions + Get access to articles in1 minute instead of 24 minutes + Increased publication frequen
Slide 12: Research Solutions is trusted by 1,500+ premier research organizations
Research Solutions is trusted by 1,500+ premier research organizations across 70 countries. Pharmaceutical Companies sanofi GSK (GGILEAD Astrazeneca novo nordiskk QOOVIe € merck Uy Novartis folmonafohnren Research Solutions Universities Carnegie Mellon University wa _ Mit EE HARVARD (if?) Universita
Slide 13: Customer testimonials
“Research Solutions [Article Galaxy] has been a big time-saver for our researchers and a cost-saver for the organization.” Dan Dowd, Chief Clinical Officer, Genomind “There are billions of scientific articles, many containing insight and solutions to issues we are facing,” Shaffer Werner said. “With
Slide 14: Market Opportunity
Market Opportunity esearcl Solutions INVESTOR PRESENTATION 14
Slide 15: Untapped market opportunity offering significant runway for growth
Untapped market opportunity offering significant runway for growth | $15B Total addressable market B2C Customers? Individual Researchers Research Solutions Research Institutes Fast growing, under-penetrated market with attractive characteristics Research-focused SaaS is projected to grow at a18.7% C
Slide 16: Nearly every industry can benefit from our research platform
Nearly every industry can benefit from our research platform, implying a wide range of potential end-users Today we serve multiple research-focused industries. Research is the backbone of progress in every industry Every research-intensive industry can benefit from using our platform, allowing for a
Slide 17: Research never stops, even during major economic downturns
Research never stops, even during major economic downturns. Worldwide R&D Expenses (% of GDP)! Research never stops, regardless of macro- economic conditions. Companies and universities have maintained a *e strong commitment to research and innovation even during periods of economic uncertainty over
Slide 18: Business Model
=> Business Model esearcl Solutions
Slide 19: Platform and transactions business lines
Platform and transactions business lines Transaction Business: 63% of revenue Business Description: Sale of individual STM articles on request, without subscription. Customers include research institutions who need specific articles not covered by their subscription or for ad-hoc research needs. Rev
Slide 20: Platform Business: Fast-growing asset with recurring revenue
Platform Business: Fast-growing asset delivering highly stable and recurring revenue with 85%+ gross margins. SaaS/Al Platforms Fastest-growing and recurring High [rat 100%)" . 4 = T™ rose Fenin sore , | RSSS Platform business key highlights Platform Transition Underwa\ ¥ Fast-growing Annual Recurri
Slide 21: Transaction: Non-cyclical business offering steady cash flows
Transaction: Non-cyclical business offering steady, predictable cash flows to fuel platform growth. RSSS Transaction business key highlights Generates revenue from the sale of individual scientific, technical, and medical (STM) documents. Customers pay per document, providing a steady stream of cash
Slide 22: Industry-leading position protected by multiple competitive advantages
RSSS's industry-leading position is protected by multiple competitive advantages built over two decades of R&D investments and customer relationships. Net renewal rates of >100%, top clients have been using our platform for years, offering very high revenue stability 85% of all publishedSTM content
Slide 23: Trusted by leading publishers, researchers, and societies
Business Model Trusted by leading publishers, researchers, and societies. Our partnerships with publishers provide us with the most complete coverage and rights in the industry. These agreements are important to ensure maximum coverage, instant access and the all-important text and data mining right
Slide 24: Financials
Financials Research Solutions INVESTOR PRESENTATION 24
Slide 25: Financials
Financials $24 Annual Recurring Revenue Cumulative B2B Deployments 1,133 1090 $22 1021 1029 $20.4 983 $20 942 $19.1 880 $17.4 $17.6 $18 815 835 $16.6 790 $15.6 $16 756 733 680 $14 $12 $11.0 $10 $9.1 $9.4 $8.8 $7.9 $8.3 $8 $7.3 $6 $4 $2 $0 Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 Q3 FY23 Q4 FY23 Q1 FY24 Q2 FY
Slide 26: Financials
Financials $8,000 $7,000 $6,725 $6,000 $5,060 $5,000 $4,000 $3,551 $3,384 $3,000 $2,418 $2,244 $2,019 $2,000 $1,868 $1,000 $576 $700 $143 $0 ($437) ($364) ($374) ($417) ($605) ($1,000) ($1,016) ($2,000) ($2,300) ($3,000) FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 (TTM) Adjusted EBITDA Cash Flow Op
Slide 27: Balance sheet supports growth
Balance sheet supports growth Clean Balance Sheet * $9.9 million in cash * $0 debt * Untapped $0.5 million line of credit Operations cash flow positive and supports organic growth Research Solutions Select balance sheet items | $ Millions veo ara | Cash and equivalents 9.9 61 Accounts receivable 7.6
Slide 28: Other Key Stats
Other Key Stats a oa 52 Week Low-High $2.32 - $4.24 Net Income (ttm) $(3.9M)** Mgmt, Directors, Employees* 16.1% Avg. Daily Vol. (3 month) 88,576 Adjusted EBITDA (ttm) $5.1M Needham Investment Management ——_g. 9% Shares Out/Diluted* 32.4M / 35.4M EV/TTM Revenue 1.7% Richard Witmer, Jr. 8.0% Cash and
Slide 29: Outlook
Outlook Research Solutions INVESTOR PRESENTATION 29
Slide 30: Outlook
Outlook The road ahead: RSSS market & business outlook sustained platform growth, expansion Continued platform growth: The company is expected to see sustained growth in its SaaS platform business, driven by increasing demand for Al and oppo rtu nities, Al cloud-based research solutions across life
Slide 31: We expect long-term margin accretion from the SaaS platform transition
We expect long-term margin accretion due to the transition towards a high-margin SaaS platform business. a | Revenue mix outlook 2 _ 87% Transition underway from transaction to platform 3 ~ Gross revenue: Platform revenue is now 37% of the group 7 ae om Margin TTM revenue, compared to 16% 3 years ag
Slide 32: Capital Allocation
Capital Allocation: Consistent reinvestments into organic growth and strategic M&A acquisitions to maximize shareholder value Profits made are reinvested to expand the reach of our Al . . . . & SaaS platform, improve the user experience, acquire Fuel organic growth by reinvesting profits more custom
Slide 33: Investment Thesis Summary
Investment Thesis Summary 33
Slide 34: Team
Team • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Slide 35: www.researchsolutions.com
© 2024 Research Solutions, Inc. All Rights Reserved www.researchsolutions.com